Antisense oligodeoxynucleotide phosphorothioate complementary to Gag mRNA blocks replication of human immunodeficiency virus type 1 in human peripheral blood cells.

Míreanna Comhchosúla

• Antisense phosphorothioate oligodeoxynucleotides targeted to the vpr gene inhibit human immunodeficiency virus type 1 replication in primary human macrophages.
  le: Balotta, C, et al.
  Foilsithe: (1993)
• Long-term treatment of human immunodeficiency virus-infected cells with antisense oligonucleotide phosphorothioates.
  le: Lisziewicz, J, et al.
  Foilsithe: (1993)
• Inhibition of Rev activity and human immunodeficiency virus type 1 replication by antisense oligodeoxynucleotide phosphorothioate analogs directed against the Rev-responsive element.
  le: Li, G, et al.
  Foilsithe: (1993)
• Inhibition of human immunodeficiency virus in early infected and chronically infected cells by antisense oligodeoxynucleotides and their phosphorothioate analogues.
  le: Agrawal, S, et al.
  Foilsithe: (1989)
• Inhibition of human immunodeficiency virus replication by antisense oligodeoxynucleotides.
  le: Goodchild, J, et al.
  Foilsithe: (1988)